BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4096122)

  • 21. Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients.
    Cranenbroek S; van der Sangen MJ; Kuijt GP; Voogd AC
    Breast Cancer Res Treat; 2005 Feb; 89(3):271-5. PubMed ID: 15754126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local recurrence of breast cancer after cytological evaluation of lumpectomy margins.
    Cox CE; Pendas S; Ku NN; Reintgen DS; Greenberg HS; Nicosia SV
    Am Surg; 1998 Jun; 64(6):533-7; discussion 537-8. PubMed ID: 9619174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic factors in breast cancer--classification in non-university hospitals].
    Willner J; Kiricuta IC; Kölbl O; Bohndorf W
    Zentralbl Chir; 1993; 118(9):525-31. PubMed ID: 8237148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ductal carcinoma in situ arising in an epithelial inclusion within an axillary lymph node.
    Srinivasan B; Allan CP; Armes JE
    Pathology; 2007 Apr; 39(2):268-9. PubMed ID: 17454760
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in axillary surgery for breast cancer--time for a tailored approach.
    Purushotham AD; Macmillan RD; Wishart GC
    Eur J Surg Oncol; 2005 Nov; 31(9):929-31. PubMed ID: 16109469
    [No Abstract]   [Full Text] [Related]  

  • 26. Metastatic breast cancer and lung cancer within the same lymph node.
    Bilimoria K; Sturgis C; Liptay M
    Int J Surg Pathol; 2007 Apr; 15(2):169. PubMed ID: 17478772
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less.
    Moffat FL
    J Surg Oncol; 2005 Feb; 89(2):53-60. PubMed ID: 15660377
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast cancer and axillary nodal status.
    Chin HW; Guerra JF
    J Can Assoc Radiol; 1980 Sep; 31(3):187-9. PubMed ID: 7419548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of local therapy for primary breast cancer by lower axillary node histology.
    Forrest AP; Roberts MM; Stewart HJ
    Eur J Cancer (1965); 1980; Suppl 1():237-42. PubMed ID: 7032935
    [No Abstract]   [Full Text] [Related]  

  • 30. Non-axillary breast cancer recurrences after sentinel node biopsy.
    van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
    J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral synchronous breast cancer. A clinical dilemma.
    Guraya SY; Khairy GA
    Saudi Med J; 2004 Dec; 25(12):2024-5. PubMed ID: 15711694
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological correlation between expression of PTHrP receptor and various prognostic factors in breast cancer without axillary lymph node metastasis.
    Suzuki Y; Tokuda Y; Saito Y; Umemura S; Osamura RY
    Tokai J Exp Clin Med; 2005 Jul; 30(2):127-32. PubMed ID: 16146204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A clinical study of recurrent breast cancer].
    Abe H; Sako H; Umeda T; Eguchi Y; Okino K; Terata N; Kodama M
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1049-54. PubMed ID: 8687220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence in the axilla after sentinel lymph node biopsy for breast cancer.
    Salmon RJ; Bouillet TH; Lewis JS; Clough KB
    Eur J Surg Oncol; 2002 Mar; 28(2):199. PubMed ID: 11884060
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
    Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
    Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The indications for postoperative adjuvant therapy in node-negative breast cancer patients].
    Asagoe T; Hanatani Y; Doi M; Miyoshi H; Hasumi T; Nagaoka N; Hanashi T; Kodaira S
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):311-6. PubMed ID: 8712824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumor properties of primary tumors and local recurrence of breast cancer].
    Torsten U; Opri F; Moreno-Richter I; Weitzel HK
    Zentralbl Gynakol; 1993; 115(3):99-104. PubMed ID: 8385409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative touch preparation cytology for margin assessment in breast-conservation surgery: does it work for lobular carcinoma?
    Valdes EK; Boolbol SK; Ali I; Feldman SM; Cohen JM
    Ann Surg Oncol; 2007 Oct; 14(10):2940-5. PubMed ID: 17632761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
    Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
    Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.